Oscar Health Inc. (NYSE: OSCR) reported Q2 EPS of $1.10, $0.73 better than the analyst estimate of $0.37. Revenue for the quarter came in at $4.88 billion versus the consensus estimate of $4.73 billion.

GUIDANCE:

Oscar Health Inc. sees FY2026 revenue of $18.7-19 billion, versus the consensus of $18.57 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.